| Monolayer-protected cluster molecules AC Templeton, WP Wuelfing, RW Murray Accounts of chemical research 33 (1), 27-36, 2000 | 3045 | 2000 |
| Nanometer gold clusters protected by surface-bound monolayers of thiolated poly (ethylene glycol) polymer electrolyte WP Wuelfing, SM Gross, DT Miles, RW Murray Journal of the American Chemical Society 120 (48), 12696-12697, 1998 | 603 | 1998 |
| Electronic conductivity of solid-state, mixed-valent, monolayer-protected Au clusters WP Wuelfing, SJ Green, JJ Pietron, DE Cliffel, RW Murray Journal of the American Chemical Society 122 (46), 11465-11472, 2000 | 370 | 2000 |
| Electron hopping through films of arenethiolate monolayer-protected gold clusters WP Wuelfing, RW Murray The Journal of Physical Chemistry B 106 (12), 3139-3145, 2002 | 210 | 2002 |
| NMR diffusion, relaxation, and spectroscopic studies of water soluble, monolayer-protected gold nanoclusters O Kohlmann, WE Steinmetz, XA Mao, WP Wuelfing, AC Templeton, ... The Journal of Physical Chemistry B 105 (37), 8801-8809, 2001 | 156 | 2001 |
| Monolayer-protected clusters: molecular precursors to metal films WP Wuelfing, FP Zamborini, AC Templeton, X Wen, H Yoon, RW Murray Chemistry of materials 13 (1), 87-95, 2000 | 154 | 2000 |
| Controlled and Reversible Formation of Nanoparticle Aggregates and Films Using Cu2+−Carboxylate Chemistry AC Templeton, FP Zamborini, WP Wuelfing, RW Murray Langmuir 16 (16), 6682-6688, 2000 | 144 | 2000 |
| Three-dimensional monolayers: Voltammetry of alkanethiolate-stabilized gold cluster molecules SJ Green, JJ Pietron, JJ Stokes, MJ Hostetler, H Vu, WP Wuelfing, ... Langmuir 14 (19), 5612-5619, 1998 | 119 | 1998 |
| Mechanism of dissolution-induced nanoparticle formation from a copovidone-based amorphous solid dispersion P Harmon, K Galipeau, W Xu, C Brown, WP Wuelfing Molecular pharmaceutics 13 (5), 1467-1481, 2016 | 114 | 2016 |
| Taylor dispersion measurements of monolayer protected clusters: a physicochemical determination of nanoparticle size WP Wuelfing, AC Templeton, JF Hicks, RW Murray Analytical Chemistry 71 (18), 4069-4074, 1999 | 102 | 1999 |
| Water-soluble, sulfonic acid-functionalized, monolayer-protected nanoparticles and an ionically conductive molten salt containing them YS Shon, WP Wuelfing, RW Murray Langmuir 17 (4), 1255-1261, 2001 | 98 | 2001 |
| Polysorbate 80 UV/vis spectral and chromatographic characteristics–defining boundary conditions for use of the surfactant in dissolution analysis WP Wuelfing, K Kosuda, AC Templeton, A Harman, MD Mowery, ... Journal of pharmaceutical and biomedical analysis 41 (3), 774-782, 2006 | 89 | 2006 |
| Detection and quantification of low-molecular-weight aldehydes in pharmaceutical excipients by headspace gas chromatography Z Li, LK Jacobus, WP Wuelfing, M Golden, GP Martin, RA Reed Journal of Chromatography A 1104 (1-2), 1-10, 2006 | 87 | 2006 |
| Accelerated forced degradation of pharmaceuticals in levitated microdroplet reactors Y Li, Y Liu, H Gao, R Helmy, WP Wuelfing, CJ Welch, RG Cooks Chemistry–A European Journal 24 (29), 7349-7353, 2018 | 50 | 2018 |
| Identification and in vivo evaluation of liver X receptor β-selective agonists for the potential treatment of Alzheimer’s disease SJ Stachel, C Zerbinatti, MT Rudd, M Cosden, S Suon, KK Nanda, ... Journal of medicinal chemistry 59 (7), 3489-3498, 2016 | 44 | 2016 |
| Development and validation of an automated extraction method (accelerated solvent extraction®) and a reverse-phase HPLC analysis method for assay of ivermectin in a meat-based … AM Abend, L Chung, DG McCollum, WP Wuelfing Journal of pharmaceutical and biomedical analysis 31 (6), 1177-1183, 2003 | 42 | 2003 |
| Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide A Peresypkin, E Dokou, C McKelvey, C DeLuca, L Alani, T Gibson, ... US Patent App. 11/667,344, 2007 | 30 | 2007 |
| Investigation of orexin-2 selective receptor antagonists: Structural modifications resulting in dual orexin receptor antagonists JW Skudlarek, CN DiMarco, K Babaoglu, AJ Roecker, JG Bruno, ... Bioorganic & Medicinal Chemistry Letters 27 (6), 1364-1370, 2017 | 26 | 2017 |
| Profiling of medium chain glycerides used in pharmaceutical formulation development by reversed-phase HPLC KA Fliszar, WP Wuelfing, Z Li, RA Reed Journal of pharmaceutical and biomedical analysis 40 (4), 896-900, 2006 | 25 | 2006 |
| Preclinical dose number and its application in understanding drug absorption risk and formulation design for preclinical species WP Wuelfing, P Daublain, F Kesisoglou, A Templeton, C McGregor Molecular Pharmaceutics 12 (4), 1031-1039, 2015 | 18 | 2015 |
Deon MilesUniversity of the SouthVerified email at sewanee.edu
